Immunitybio is trading at $10.09, down 4.04% in the live session on October 12, 2026; no clear company-specific catalyst was identified.
- Major indices were mixed, with none moving more than 0.5% in the same direction as the stock.
- The Piper Sandler symposium appearance is scheduled for October 15–16; an insider planned-sale filing was dated October 5. Neither establishes a cause for the decline.
- Trading volume information was unavailable in the provided context or sources.